Table 3.
Tissues where validated imprinted genes most likely had biallelic expression
| SNP(rs#) | Chr | Location | Str | Posterior | Gene ID | Gene Symbol | Tissue | Group |
|---|---|---|---|---|---|---|---|---|
| 3807551 |
chr7 |
50627897 |
- |
6.84E-17 |
2887 |
GRB10 |
Skeletal Muscle |
I |
| 2585 |
chr11 |
2107019 |
+ |
9.09E-210 |
3481 |
IGF2 |
Liver |
I |
| 10770125 |
chr11 |
2125589 |
+ |
7.15E-43 |
3481 |
IGF2 |
Liver |
I |
| 8813 |
chr11 |
3065081 |
- |
1.20E-11 |
114879 |
OSBPL5 |
Colon |
I |
| 17178177 |
chr11 |
3065446 |
+ |
6.83E-10 |
114879 |
OSBPL5 |
Colon |
I |
| 10770125 |
chr11 |
2125589 |
+ |
7.15E-43 |
51214 |
IGF2AS |
Liver |
I |
| 7121 |
chr20 |
56912201 |
+ |
0 |
2778 |
GNAS |
Lymph node |
I |
| 854547 |
chr7 |
94761791 |
+ |
1.61E-10 |
55607 |
PPP1R9A |
Cerebellum |
II |
| 8164 |
chr11 |
6372457 |
+ |
1.54E-30 |
6609 |
SMPD1 |
Cerebellum |
II |
| 7951904 |
chr11 |
6369506 |
+ |
2.68E-10 |
6609 |
SMPD1 |
Cerebellum |
II |
| 11601088 |
chr11 |
6371967 |
+ |
1.62E-09 |
6609 |
SMPD1 |
Cerebellum |
II |
| 2272666 |
chr8 |
1.46E+08 |
+ |
2.63E-17 |
79581 |
GPR172A |
Cerebellum |
II |
| 2280840 |
chr8 |
1.46E+08 |
+ |
1.05E-57 |
79581 |
GPR172A |
Cerebellum |
II |
| 2615374 | chr8 | 1.41E+08 | + | 1.51E-13 | 51305 | KCNK9 | Cerebellum | II |
Posteriors were calculated based on Group I or II (see Table 5). The “Tissue” column indicates where genes were most likely biallelically expressed. Genes with contradictory evidence (i.e., genes had posteriors <10-8 and posteriors ≥0.2) were discarded. IGF2, OSBPL5, SMPD1 and GPR172A had at least 2 SNPs with posteriors less than 10-8. Abbreviations are the same as in Table 2.